Edwardsiella tarda, a bacterial pathogen to farmed fish as well as humans, possesses the genes of two lysozyme inhibitors, ivy and mliC (ivy Et and mliC Et ). We recently studied Ivy Et and found it to be implicated in E. tarda virulence. In the present study, we characterized MliC Et in comparison with Ivy Et in a turbot model. MliC Et contains the FWSKG motif and two cysteines (C33 and C98) that are highly conserved in subgroup 1 MliCs but are of unknown functional importance. To examine the essentialness of these conserved structural features, recombinant MliC Et (rMliC) and its mutants bearing C33S and W79A (of the FWSKG motif) substitutions were prepared. Subsequent analysis showed that rMliC (i) inhibited lysozyme-induced lysis of a Gram-positive bacterium, (ii) reduced serum-facilitated lysozyme killing of E. tarda, and (iii) when introduced into turbot, promoted bacterial dissemination in fish tissues. The C33S mutation had no influence on the activity of rMliC, while the W79A mutation slightly but significantly enhanced the activity of rMliC. Knockout strains of either mliC Et or ivy Et were severely attenuated for the ability of tissue invasion, host lethality, serum survival, and intracellular replication. The lost virulence of the mliC transformant (TX⌬mliC) was restored by complementation with an introduced mliC Et gene. Compared to the ⌬ivy Et or ⌬mliC Et singleknockout strains, the ⌬mliC Et ⌬ivy Et double-knockout strain was significantly impaired in most of the virulence features. Together, these results provide the first evidence that the conserved cysteine is functionally dispensable to a subgroup 1 MliC and that as a virulence factor, MliC Et most likely works in a concerted and parallel manner with Ivy.
E
dwardsiella tarda is a rod-shaped Gram-negative bacterium of the family Enterobacteriaceae. It is a zoonotic pathogen that can infect fish, birds, reptiles, and humans (1) . In aquaculture, E. tarda is known to affect a large number of freshwater and marine fish and has caused heavy economic losses (2) . As a human pathogen, E. tarda is the etiological agent of gastroenteritis and extraintestinal diseases, such as peritonitis, meningitis, and myonecrosis (3) . Recent studies with different fish models revealed that E. tarda infection requires the participation of a wide range of factors, including exoenzymes, adhesin, invasin, type III and type VI secretion systems, a quorum-sensing system, two-component systems, and iron assimilation and utilization systems (4, 5) .
Lysozymes play a key role in innate immunity in all animals. They catalyze the hydrolysis of the ␤-1,4-glycosidic bond between the N-acetylmuramic acid and N-acetylglucosamine of bacterial peptidoglycan, resulting in peptidoglycan degradation and cell lysis (6, 7) . To date, three major classes of animal lysozymes have been identified, of which, chicken (C)-and goose (G)-type lysozymes are present in all vertebrates, while the I-type lysozyme is found only in invertebrates. The three types of lysozymes differ considerably in amino acid sequence but are similar in three-dimensional structure (8) . In mammals, lysozymes are involved in modulation of inflammation and the immune response and constitute part of the defensive bactericidal system (9, 10) .
As a strategy to protect themselves from the action of lysozymes, bacteria have developed specific evasion mechanisms by producing a group of proteins called lysozyme inhibitors, which interact with and block the activity of different lysozymes (11, 12) . To date, inhibitors against all three major types of lysozymes have been identified in Gram-negative bacteria. These inhibitors are known as inhibitor of vertebrate lysozyme (Ivy) proteins, which target C-type lysozyme, periplasmic lysozyme inhibitor of C-type lysozyme (PliC), membrane-associated lysozyme inhibitor of Ctype lysozyme (MliC), periplasmic inhibitor of I-type lysozyme (PliI), and periplasmic inhibitor of G-type lysozyme (PliG) (13) (14) (15) (16) (17) . Of these inhibitors, MliC/PliC have been found in various bacterial species, and high-resolution structures of the MliCs/ PliCs of Escherichia coli, Pseudomonas aeruginosa, Salmonella enterica serovar Typhimurium, and Brucella abortus have been reported (18) (19) (20) (21) . It seems that MliC proteins fall into two subgroups, which differ in dimer formation. Subgroup 1 is represented by the E. coli MliC (MliC Ec ), which exists as a monomer in solution (18) , while subgroup 2, which includes P. aeruginosa MliC (MliC Pa ) and B. abortus PliC, appear to be dimeric proteins in their crystal structures (19, 21) .
In a previous study, we identified and characterized the Ivy of E. tarda (Ivy Et ). We found that Ivy Et is able to inhibit the activity of C-type lysozyme and is involved in the pathogenesis of E. tarda (22) . In the present study, we aimed to examine the biological activity of MliC of E. tarda and assess the role of MliC in bacterial infection in comparison with that of Ivy Et . Our results provide pJTMliC that expressed mliC Et , mliC Et was amplified by PCR with primers F1/R1, the PCR product was ligated with the TA cloning vector pBS-T, and the recombinant plasmid was digested with EcoRV. The fragment containing mliC Et was retrieved and inserted into plasmid pBT3 (25) at the EcoRV site, resulting in pBT3MliC. pBT3MliC was digested with SwaI, and the fragment carrying mliC Et was inserted into plasmid pJT (26) at the SwaI site, resulting in pJTMliC. All PCR products were verified by sequence analysis.
Construction of the ⌬mliC Et and ⌬ivy Et knockouts. To construct E. tarda TX⌬mliC, an in-frame deletion of a 237-bp segment (residues 31 to 267) of mliC Et was created by overlap extension PCR as follows: the first overlap PCR was performed with primers F4 and R4, the second overlap PCR was performed with primers F5 and R5, and the fusion PCR was performed with the primer pair F4/R5. The PCR product was inserted into the suicide plasmid pDM4 (27) at the BglII site, resulting in pDMMliC. S17-1 pir was transformed with pDMMliC, and the transformants were conjugated with TX01 as follows. The donor and recipient strains were cultured in LB medium to an optical density at 600 nm (OD 600 ) of 0.8 and mixed at a ratio of 3:1. The mixture was dropped onto an LB agar plate, and the plate was incubated at 28°C for 24 h. After incubation, the bacteria on the plate were resuspended in 2 ml LB and plated on an LB agar plate containing polymyxin B and chloramphenicol. The colonies that appeared were selected on LB agar plates containing 10% sucrose. One of the colonies that was resistant to sucrose and sensitive to chloramphenicol was analyzed by PCR, and the PCR product was sequenced to confirm in-frame deletion of mliC Et . This strain was named TX⌬mliC. TX⌬ivy has been reported previously (previously named TXivy) (22) . To construct the ⌬mliC Et ⌬ivy Et double knockout, S17-1 pir was transformed with pDMMliC, the transformants were conjugated with TX⌬ivy, and the transconjugants were selected as described above. One of the transconjugants was named TX⌬mliC⌬ivy. All mliC Et and ivy Et single and double deletions in the respective knockout strains were confirmed by PCR. To construct the mliC Et complement strain TX⌬mliC/mliC, S17-1 pir was transformed with pJTMliC and the transformants were conjugated with TX⌬mliC. The transconjugants were selected on LB agar plates supplemented with tetracycline (a marker of pJT) and polymyxin B (a marker of TX01 and its derivatives). One of the transformants was named TX⌬mliC/ mliC.
Purification of recombinant proteins. E. coli BL21(DE3) was transformed separately with pEtMliC, pEtMliCC33S, pEtMliCW79A, and pET32a for purification of the His-tagged rMliC, rMliCC33S, rMliCW79A, and rTrx tags, respectively. rTrx was used as a control protein in the functional study of rMliC Et , rMliCC33S, and rMliCW79A, since, as indicated above, the latter three proteins are expressed from pET32a and consequently bear a Trx tag as well as a His tag. The transformants were cultured in LB medium at 37°C to mid-logarithmic phase, and expression of recombinant proteins was induced by adding isopropyl-␤-D-thiogalactopyranoside to a final concentration of 1 mM. After growth at 18°C for an additional 12 h, the cells were harvested by centrifugation, and the proteins were purified using Ni-nitrilotriacetic acid agarose (Qiagen, Valencia, CA) as recommended by the manufacturer. The purified proteins were reconstituted by dialyzing against reconstitution buffer (50 mM Tris-HCl, 50 mM NaCl, 5 mM ␤-mercaptoethanol, 5 mM EDTA, 20% glycerol, 2 mM reduced glutathione, 0.2 mM oxide glutathione, and a gradient of 6 M, 4 M, 2 M, 1 M, 0.5 M, and 0 M urea; pH 8.5) at 4°C, with 12 h of dialysis at each gradient. The proteins were then dialyzed in phosphate-buffered saline (PBS) for 24 h. The proteins were treated with Triton X-114 to remove endotoxin as described previously (28) . The proteins were concentrated using polyethylene glycol 20000 (Solarbio, Beijing, China). The concentrated proteins were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and visualized after staining with Coomassie brilliant blue R-250. The concentrations of the proteins were determined using the Bradford method with bovine serum albumin as the standard. Immunoblot assays. TX01 was cultured in LB medium to an OD 600 of 0.8. Extracellular and whole-cell proteins were prepared and subjected to immunoblotting as reported previously (25) with rat antibodies against recombinant MliC and LuxS (29) . The antibodies were prepared as reported previously (30) .
Lysozyme inhibitor activity assay. (i) With M. luteus as the target bacterium. M. luteus was cultured in LB medium to an OD 600 of 0.8 and washed with PBS for the lysozyme inhibitor assay. Hen egg white lysozyme (HEWL; Solarbio, Beijing, China) was added to the bacterial suspension to a final concentration of 5 g/ml. The same volume of PBS was added to the control sample. The cells were then mixed with different concentrations (10 M, 40 M, or 80 M) of rMliC or rTrx. The mixture was incubated at 37°C. After 30 min, 60 min, 90 min, and 120 min of incubation, an aliquot of cells was diluted serially and plated on LB agar plates. The plates were incubated at 37°C for 24 h, and the colonies that appeared on the plates were counted. The genetic identities of the colonies were verified by PCR with specific primers and sequence analysis of the PCR products.
(ii) With E. tarda as the target bacterium. E. tarda TX01 was cultured in LB medium to an OD 600 of 0.8 for the lysozyme inhibitor assay. The cells were washed with PBS and resuspended in PBS to 10 7 CFU/ml. Turbot serum was diluted three times in PBS. Ten microliters of bacterial cells was mixed with or without (control) 50 l diluted serum. HEWL (final concentration, 100 g/ml) or HEWL plus rMliC (final concentration, 80 M) was then added to the cells. The control cells were treated with PBS. The cells were incubated at 28°C for 2 h. After incubation, the cells were serially diluted and plated on LB agar plates. The plates were incubated at 28°C for 48 h, and the colonies that appeared on the plates were enumerated.
In vivo effect of rMliC on E. tarda infection. TX01 and TX⌬mliC were cultured as described above and resuspended in PBS to 5 ϫ 10 5 CFU/ml. Turbot were randomly divided into three groups and injected intraperitoneally with 100 l 80 M rMliC, rTrx, or PBS. At 4 h postinjection, turbot in each group were infected via intramuscular injection with 100 l TX01 or TX⌬mliC. At 8 h postinfection, kidneys and spleens were aseptically taken from the fish (five fish/time point) and homogenized in PBS. The homogenates were serially diluted and plated in triplicate on LB agar plates. The plates were incubated at 28°C for 48 h, and the colonies that appeared on the plates were enumerated. The genetic identities of the colonies were verified by PCR with E. tarda-specific primers and sequence analysis of the PCR products.
Tissue dissemination and mortality analysis. For tissue dissemination analysis, E. tarda TX01, TX⌬mliC/mliC, TX⌬mliC, TX⌬ivy, and TX⌬mliC⌬ivy were cultured in LB medium to an OD 600 of 0.8. The cells were washed with PBS and resuspended in PBS to 5 ϫ 10 5 CFU/ml. Turbot were randomly divided into five groups (n ϭ 35) and infected via intramuscular injection with 100 l TX01, TX⌬mliC/mliC, TX⌬mliC, TX⌬ivy, or TX⌬mliC⌬ivy. At 12 h, 24 h, and 48 h postinfection, kidneys and spleens were aseptically taken from the fish (five fish/time point) and homogenized in PBS. The homogenates were serially diluted and plated in triplicate on LB agar plates. The plates were incubated at 28°C for 48 h, and the colonies that appeared on the plates were enumerated. For mortality analysis, five groups (n ϭ 20) of turbot were infected as described above with TX01, TX⌬mliC/mliC, TX⌬mliC, TX⌬ivy, or TX⌬mliC⌬ivy; the fish were monitored daily for mortality for 15 days.
Serum survival assay. E. tarda TX01, TX⌬mliC/mliC, TX⌬mliC, TX⌬ivy, and TX⌬mliC⌬ivy were cultured in LB medium to an OD 600 of 0.8. The cells were washed with PBS and resuspended in PBS. Approximately 10 5 bacterial cells were mixed with 50 l untreated turbot serum or heat-inactivated turbot serum (control). After incubation with mild agitation at 28°C for 60 min, the mixtures were serially diluted and plated in triplicate on LB agar plates. The plates were incubated at 28°C for 48 h, and the colonies that appeared on the plates were enumerated. The genetic identities of the colonies were verified as described above. The survival rate was calculated as follows: [(number of serum-treated cells)/(number of heat-inactivated serum-treated cells)] ϫ 100%.
Bacterial replication in HKM. Turbot head kidney monocytes (HKM) were prepared as follows. Head kidney was taken from the turbot (ϳ812 g) under aseptic conditions. The tissues were ground and passed through a sterile metal mesh (75 mm) with PBS containing 10% fetal bovine serum (FBS; Gibco, Life Technologies, Carlsbad, CA). The cell suspension was centrifuged at 300 ϫ g for 5 min, and the cell pellet was washed and resuspended in PBS containing 10% FBS. HKM were extracted from the cell suspension by using a fish monocyte separation kit (Hao Yang Biological Manufacture Co., Tianjin, China) (see Fig. S1 in the supplemental material). The cells were cultured in L-15 medium (Thermo Scientific HyClone, Beijing, China) in 96-well culture plates (10 5 cells/ well). TX01, TX⌬mliC/mliC, TX⌬mliC, TX⌬ivy, and TX⌬mliC⌬ivy were prepared as described above and added to HKM (10 5 CFU/well). The cells were incubated at 28°C for 1 h and washed three times with PBS. Fresh L-15 medium containing 100 g/ml gentamicin (Thermo Scientific HyClone, Beijing, China) was added to the cells, and the cells were incubated at 28°C for 1 h to kill extracellular bacteria. The plates were then washed three times with PBS and incubated at 28°C for 0 h, 2 h, 4 h, and 8 h. After incubation, the plates were washed with PBS, and the cells were lysed with 100 l 1% Triton X-100. The cell lysate was serially diluted and plated in triplicate on LB agar plates. The plates were incubated at 28°C for 48 h, and the colonies that emerged on the plates were counted. The identities of the colonies were verified as described above.
Production of ROS and acid phosphatase activity assay. Reactive oxygen species (ROS) production was determined as reported previously (31) . For acid phosphatase activity analysis, E. tarda TX01, TX⌬mliC/ mliC, TX⌬mliC, TX⌬ivy, and TX⌬mliC⌬ivy were prepared as described above and added to HKM cultured as described above (10 5 CFU/well). The same volume of PBS was added to the control cells. The cells were incubated at 28°C for 2 h or 4 h, followed by washing three times with PBS. After incubation, the acid phosphatase activities of the cells were determined as follows: the cells were lysed by adding 100 l of 1% Triton X-100 to each well, followed by incubation at 4°C for 20 min. After incubation, acid phosphatase activity was determined by using an acid phosphatase assay kit (Beyotime, Beijing, China) according to the manufacturer's instructions.
Statistical analysis. All experiments were performed three times (as indicated in the figure legends). Except for the mortality assay, in which a log rank test was used to compare the survival distributions of the fish, all other statistical analyses were performed using analysis of variance (ANOVA) within the SPSS 15.0 package (SPSS Inc., Chicago, IL). In all cases, the significance level was defined as a P value of Ͻ0.05.
RESULTS

Sequence of MliC Et .
A search of the genomes of several E. tarda isolates for lysozyme inhibitor genes revealed that, in addition to ivy Et , E. tarda possesses an mliC homologue (named mliC Et ). Sequence analysis showed that MliC Et is composed of 102 amino acid residues, with a predicted molecular mass of 11.55 kDa and a pI of 9.24. It is most closely related to the MliC of Edwardsiella ictaluri (88% overall identity), moderately related to the MliCs of a number of bacteria, including Pantoea stewartii, Yersinia enterocolitica, Klebsiella pneumoniae, and E. coli (40.4% to 56.2% overall identity), and distantly related to the MliC of P. aeruginosa (23.6% overall identity) (see Fig. S2 in the supplemental material) 82 that is universally present in subgroup 1 MliCs. Lysozyme-inhibitory activity of rMliC. Since lysozyme inhibitors in their natural forms are usually difficult to obtain, especially with relatively high purity, these proteins have been studied in the form of recombinant proteins (13, 17, 20, 21, 32) . In our study, to examine the biological activity of MliC Et , rMliC was purified from E. coli as a Trx-tagged protein. To examine the antilysozyme effect of rMliC, M. luteus was incubated with HEWL in the presence or absence of different concentrations of rMliC, and bacterial survival was then determined. The results showed that the presence of rMliC, but not rTrx, which was purified under the same conditions as rMliC, significantly increased bacterial survival in a manner that depended on the dose of rMliC (Fig. 1) .
Effect of rMliC on survival of E. tarda. (i) In vitro effect. Serum-facilitated lysozyme killing analysis showed that when E. tarda TX01 was incubated with HEWL in the presence of diluted turbot serum, which served to sensitize the bacterium to lysozyme, bacterial survival was significantly reduced; however, when E. tarda TX01 was incubated with HEWL in the presence of turbot serum plus rMliC, bacterial survival increased to a level comparable to that of the control cells treated with PBS (Fig. 2) .
(ii) In vivo effect on E. tarda infection. To examine whether rMliC could affect the infectivity of E. tarda, turbot were inoculated with E. tarda TX01 in the presence or absence of rMliC or rTrx, and bacterial dissemination into and colonization of the spleen and kidney of the fish were determined. The results showed that in the presence of rMliC, bacterial recoveries from both tissues were significantly increased, whereas in the presence of rTrx, bacterial loads in the tissues were comparable to those of the control fish (Fig. 3) .
Extracellular production of MliC Et . With the above results, which showed that rMliC as an exogenously added protein functioned in vivo, we wondered whether TX01 could naturally produce MliC Et into the extracellular milieu. To investigate this question, immunoblotting was conducted to examine the potential existence of MliC Et in the extracellular as well as the whole-cell proteins of TX01. The results showed that anti-rMliC antibodies detected MliC Et in both fractions (see Fig. S3 in the supplemental material). When the antibodies against LuxS, a cytoplasmic protein of E. tarda (29) , were used in the immunoblot assay, LuxS was detected in the fraction of whole-cell proteins but not in the fraction of extracellular proteins, which ruled out the possibility that the MliC Et detected in the extracellular fraction was due to contamination of cytoplasmic proteins.
Functional importance of the conserved residues of rMliC. Since the residues C33 and W79 are highly conserved among known MliC proteins, we examined the functional importance of these residues for the activity of rMliC. For this purpose, the mutant proteins rMliCC33S and rMliCW79A, which bore C33S and W79A substitutions, respectively, were prepared and examined for lysozyme-inhibitory activity. The results showed that the survival rates of M. luteus after incubation with HEWL plus rMliCC33S were similar to those after incubation with HEWL plus rMliC (Fig. 4) . Compared to M. luteus incubated with HEWL plus rMliC, M. luteus incubated with HEWL plus rMliCW79A exhibited similar survival rates after 30 min to 90 min of incubation; however, when the incubation was extended to 120 min, the survival rate of rMliCW79A-treated cells was slightly but significantly (P Ͻ 0.05) increased above that of rMliC-treated cells (Fig. 4) .
Construction of ⌬mliC Et single-knockout and ⌬mliC Et ⌬ivy Et double-knockout strains. Since, as stated above, E. tarda possesses two lysozyme inhibitor genes, i.e., ivy Et and mliC Et , of which ivy Et is known to be involved in bacterial pathogenesis (22), we wanted to examine the biological significance of MliC Et in comparison with that of Ivy Et . For this purpose, two genetic variants of TX01 were created, i.e., TX⌬mliC and TX⌬mliC⌬ivy, which are the mliC Et knockout and mliC Et ivy Et double knockout, respectively. Growth analysis showed that, like TX⌬ivy, which exhibited no growth defect compared to the wild-type strain TX01 (22) , TX⌬mliC and TX⌬mliC⌬ivy displayed growth profiles similar to that of TX01 when cultured in LB medium (data not shown).
Comparison of the infectivity of mutant and wild-type E. tarda in different aspects. (i) Capacity to disseminate in host tissues and to cause host mortality. To compare their in vivo infectivity, the mutant and wild-type E. tarda were inoculated into turbot via muscle injection. In addition, in order to examine whether any effect caused by the ⌬mliC Et mutation could be rescued by an exogenously introduced mliC Et allele, the strain TX⌬mliC/mliC, which is TX⌬mliC harboring a low-copy-number plasmid that expresses mliC Et , was similarly inoculated into turbot. At 12 h, 24 h, and 48 h postinfection, bacterial dissemination and colonization in kidney and spleen were determined by plate count. The results showed that in both tissues and at all examined time points, the numbers of bacteria recovered from TX⌬mliC-and TX⌬ivy-infected fish were comparable and significantly lower than those from TX01-infected fish, while the bacterial recoveries from TX⌬mliC⌬ivy-infected fish were significantly lower than those from either TX⌬mliC-or TX⌬ivy-infected fish (Fig. 5) . In contrast, bacterial recoveries from fish infected with TX⌬mliC/mliC were similar to those from TX01-infected fish. To examine whether rMliC had any effect on TX⌬mliC infection, turbot were infected with TX⌬mliC in the presence of rMliC or rTrx, and bacterial recoveries from kidney and spleen were determined at 8 h postinfection. The results showed that for both tissues, the bacterial loads in the fish treated with rMliC were significantly higher than those in the untreated control fish or in the fish treated with rTrx (Fig. 3) .
Mortality analysis showed that mortality began to occur at 3 days postinfection in fish infected with TX01 or TX⌬mliC/mliC and at 4 days postinfection in fish infected with TX⌬mliC or TX⌬ivy. At the end of the monitored period, the survival rates of TX⌬mliC⌬ivy-, TX⌬mliC-, and TX⌬ivy-infected fish were 100%, 55%, and 65%, respectively, which were significantly higher than those of the fish infected with TX01 or TX⌬mliC/mliC (0%) (Fig. 6) .
(ii) Capacity to resist the bactericidal effect of host serum. The ability to survive in host serum is a key virulence property of E. tarda (29, 30) . When incubated with turbot serum, TX⌬mliC was found to exhibit a significantly lower survival rate than the wild-type TX01 (Fig. 7) . The survival rate of TX⌬mliC was com- parable to that of TX⌬ivy but was significantly higher than that of TX⌬mliC⌬ivy (Fig. 7) . In contrast to the mutants, TX⌬mliC/mliC was comparable to TX01 in survival rate.
(iii) Capacity to replicate in host HKM and to inhibit HKM activation. Another feature that is vital to E. tarda infection is the ability to replicate in host phagocytes and to block activation of these cells. An intracellular infection study showed that, when the mutants and wild-type E. tarda were incubated with turbot HKM, the intracellular bacterial recoveries of TX01 and TX⌬mliC/mliC increased steadily with time during the monitored period, whereas no apparent increase in the intracellular number of TX⌬mliC, TX⌬ivy, or TX⌬mliC⌬ivy cells was detected (Fig. 8) . Compared to TX01-infectcted HKM, HKM infected with TX⌬mliC, TX⌬ivy, or TX⌬mliC⌬ivy exhibited no apparent difference in ROS production (data not shown); however, HKM infected with the three mutants, in particular TX⌬mliC⌬ivy, exhibited significantly higher levels of acid phosphatase activity (Fig. 9) .
DISCUSSION
In this study, we examined the biological activity and function of the E. tarda MliC, MliC Et . We found that MliC Et in the primary structure is closer to subgroup 1 MliCs, represented by MliC Ec , than to subgroup 2 MliCs, represented by MliC Pa . It is known that subgroup 2 MliCs contain conserved residues, such as L34, L36, L62, L69, and V81 in MliC Pa , that are involved in hydrophobic interactions at the dimeric interface, whereas in subgroup 1 MliCs this feature is lacking (18) . In MliC Et , none of the hydrophobic residues conserved in subgroup 2 MliC is present. In contrast, MliC Et possesses the FWSKG motif that is universally preserved in subgroup 1 MliCs and likely participates in substrate binding (18) . These structural characteristics indicated that MliC Et is a member of subgroup 1 MliCs.
Lysozyme-inhibiting activity has been reported for MliC Ec and MliC Pa (14) . In the case of MliC Et , we observed a dose-dependent inhibitory effect of rMliC against HEWL-induced lysis of M. luteus, suggesting that MliC Et is an active lysozyme inhibitor. In documented studies of recombinant lysozyme inhibitors, the recombinant proteins were used at the dose of 10 M to 200 M for different analyses (13, 17) ; in our study, the concentration of rMliC used (80 M) relatively high based on the consideration that the protein had undergone reconstitution. Previous studies showed that in the presence of outer membrane permeabilizers or antimicrobials that destabilize the outer membrane of Gram-negative bacteria, lysozymes can effectively kill Gram-negative bacteria (14, 16, 17, (33) (34) (35) . In our study, we found that in the presence of diluted fish serum, which facilitates the action of lysozymes on Gram-negative bacteria, rMliC reduced the killing effect of HEWL The fish were monitored daily for mortality and survival. Significance levels between the survival of TX01-infected fish compared to other groups of fish were determined with a log rank test. The experiment was performed three times, and the mean survival rates are shown. **, P Ͻ 0.01. against E. tarda to a significant extent. Since the serum was from turbot, the susceptible host of E. tarda, this in vitro observation suggested that rMliC may function in vivo as well. Consistently, the presence of rMliC significantly enhanced the ability of TX01 and TX⌬mliC to disseminate into and colonize host tissues. It is likely that although TX01 can produce MliC Et during infection, the mount of naturally produced MliC Et may not be enough to combat host lysozymes in the sense that some of the inoculated bacteria are inevitably killed by lysozyme-induced lysis. However, when the infection was conducted in the presence of rMliC, the exogenously added protein inactivated a certain amount of host lysozymes and thus enabled more bacterial cells to escape from lysozyme killing, which led to faster and more effective tissue dissemination and colonization. In line with the in vivo observations, immunoblotting detected MliC Et in the culture supernatant of TX01, suggesting that MliC Et is produced extracellularly by the pathogen. These results suggest that MliC Et likely functions, at least in part, as an extracellular lysozyme inhibitor.
A nuclear magnetic resonance structural study showed that MliC Ec folds into an eight-stranded antiparallel ␤-barrel that is stabilized by an intramolecular disulfide bond formed by the only two cysteine residues in the protein and that a conserved patch on the open end of the barrel, composed of the sequences SASGARY and FWSKG, represents a possible site for substrate binding or protein-protein interaction (18) . However, the real functional importance of these conserved structures in subgroup 1 MliCs has not been investigated. In our study, to ascertain the essentialness of the conserved residues, we compared the activities of wild-type MilC Et and mutant MilC Et bearing substitutions at the W residue of the FWSKG motif and at one of the highly conserved cysteine residues. We found that rMliCC33S was comparable to rMliC in activity, suggesting that C33, and consequently the intracellular disulfide linkage, is functionally dispensable. In contrast to rMliCC33S, rMliCW79A exhibited slightly but significantly stronger lysozyme-inhibitory activity than rMliC. Considering that subgroup 1 MliCs exist as a monomer, FWSKG is more likely involved in substrate binding than in protein dimerization. As such, it is possible that W79 may participate in the hydrophobic interaction with key residues of lysozyme and that replacement of W79 with alanine, which like tryptophan has a hydrophobic side chain, but is much smaller in size, may result in better substrate interactions and hence an augmented inhibitory effect on lysozyme.
Several reports have shown that lysozyme inhibitors are implicated in bacterial pathogenesis; however, variations exist among different bacterial species. For example, in E. coli, Ivy is known to enhance bacterial survival in human saliva (36) , and knockout of mliC, but not ivy, decreased the serum survival and lethality of the bacterium (12) . In plague-causing Yersinia pestis, deletion of mliC had no effect on lysozyme resistance or the development of plague, while deletion of ivy attenuated bacterial virulence (37) . In E. tarda, our recent study showed that knockout of ivy Et reduced bacterial virulence in various aspects (22) . Similarly, in the present study, we found that compared to the wild type, TX⌬mliC was impaired in the ability for tissue dissemination, inducing mortality in the host, and resistance against the bactericidal activity of host serum, most likely due to the reduced capacity of TX⌬mliC to combat the lysozymes present in host tissues and serum. Previous studies showed that in S. enterica serovar Typhi, mliC expression was expressed during growth in human macrophages and that mliC disruption led to decreased survival of the bacteria in macrophages (38, 39) . In E. tarda, which is known to be capable of replicating in phagocytes and inhibiting the host immune response (40-42), we found that, unlike the wild type, TX⌬mliC was unable to multiplicate in turbot HKM, suggesting that MliC Et is required for intracellular replication. Consistent with this observation, the acid phosphatase activity of TX⌬mliC-infected cells was significantly higher than that of TX01-infected cells, suggesting that TX⌬mliC was defective in blocking HKM activation in some aspects. The observation that TX⌬mliC/mliC exhibited virulence features comparable to those of the wild-type strain indicates that the genetic defect of TX⌬mliC can be complemented by the introduced mliC Et in TX⌬mliC/mliC, which supports the conclusion that the alterations in the virulence properties of TX⌬mliC were indeed due to mliC Et knockout.
In a recent study of the lysozyme inhibitors of an avian pathogenic E. coli, it was observed that mliC knockout reduced serum resistance, but ivy knockout and ivy mliC double knockout had no effect on serum resistance and that while mliC knockout was attenuated in virulence, the ivy mliC double knockout exhibited a full virulence capacity, almost like that of the wild type (12) . In contrast, in E. tarda we found that TX⌬mliC was similar to TX⌬ivy in virulence properties and that in the abilities of tissue dissemination, serum resistance, and host lethality, the mliC Et ivy Et double-knockout strain TX⌬mliC⌬ivy was significantly weakened compared to either the mliC Et or ivy Et single knockout. These results indicated that MliC Et and Ivy Et are not functionally exchangeable; rather, it is more likely that these two proteins act in a concerted manner that produces an additive effect on bacterial infectivity. This lack of functional redundancy is in line with the fact that mliC Et and ivy Et are the only lysozyme inhibitor genes possessed by E. tarda.
In conclusion, in this study we demonstrated that MliC Et is a lysozyme inhibitor implicated in various aspects of bacterial virulence and required for host infection. We observed for the first time that the biological activity of a subgroup 1 MliC is independent of the highly conserved cysteine residue involved in intracellular disulfide bond formation and that MliC Et as a virulence factor probably works in a parallel, nonredundant manner with Ivy Et . These results add new insights into the function of as well as the function-structure relationship of MliC.
